New: Sunrise Educational Fund to support high school and college students enrolled in our programs <<click here>>

Living Science

The Baruch S. Blumberg Institute is the nation’s leading translational research organization dedicated to finding a cure for hepatitis B and liver cancer in our lifetime.

Our Life-Saving Liver Disease Research Depends on People Like You

The Baruch S. Blumberg Institute is the nation’s leading nonprofit translational research organization dedicated to finding a cure for HBV and liver cancer in our lifetime. We find new solutions through research programs, which include drug research, biomarker discovery and other forms of biotechnology. With our goal being cures for diseases such as chronic hepatitis, liver disease and liver cancer, we do all of our research in environments that are conducive to interaction, collaboration and focus.

Upcoming Seminars

  • Distinguished Speaker Seminar Series

    We host a distinguished professional Seminar Series to promote scientific exchange at a national and international level. Renowned leaders in the field are invited to speak on a regular schedule, which is free and open to the interested public.

Research Highlights

New president announced for the Pennsylvania Biotechnology Center (PABC)

Louis P.  Kassa, executive vice president and chief operating officer of the nonprofit Pennsylvania Biotechnology Center (PABC), will become the center’s president in July 2022. He will succeed Timothy M. Block, PhD, who made the announcement  Sept. 27. Dr. Block will become executive chair of the Hepatitis B Foundation Board of Directors, which governs the PABC and its two sister organizations, the Hepatitis B Foundation and Baruch S. Blumberg Institute. Please read more here.

The Blumberg Institute and Harrisburg University introduce biotech workforce leadership development programs

The Baruch S. Blumberg Institute and Harrisburg University of Science and Technology have teamed to offer graduate-level biotechnology certificates to prepare working professionals with workforce and leadership skills within the biotechnology industry.

Read More

Precision medicine approaches and potential new treatment for breast cancer reported published by Blumberg scientists

A team of researchers at the Blumberg Institute is producing new insights into the treatment of breast cancer, particularly triple-negative breast cancer. 

Read More

Pennsylvania Biotechnology Center (PABC) announce $5 million investment from Bucks County Employees' Retirement Board

The nonprofit Pennsylvania Biotechnology Center (PABC), one of the nation’s most successful life sciences incubators, today announced a major pledge by a local government agency to invest in the Hatch Biofund. 

Read More

Major global biopharmaceutical company invests $10 million in Hatch Biofund

The Baruch S. Blumberg Institute, which manages the Pennsylvania Biotechnology Center (PABC),  established the Hatch Biofund to support research and development by PABC-member companies. 

Read More

New! Video About the Blumberg Institute

The Baruch S. Blumberg Institute is an independent nonprofit research institute, established in 2003 by the Hepatitis B. Foundation to advance its research mission. Watch this brief overview video of what the Blumberg Institute is about.

Read More  

Two powerful editorials published by the Hepatitis B Foundation

We have published two new editorials in honor of Hepatitis Awareness Month (May). 

Read More

Arbutus announces single-dose week 12 data in chronic hepatitis B subjects 

Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today reports positive follow-up data from a Phase 1a/1b clinical trial.

Read More

New! Learn about the Blumberg Institute

The Baruch S. Blumberg Institute is an independent nonprofit research institute, established in 2003 by the Hepatitis B. Foundation to advance its research mission. Watch this brief overview video of what the Blumberg Institute is about.

Read More  

Leading the way to a cure

Over the past year, Blumberg scientists have seen success with compounds moving into clinical trials as well as with basic science discovery. We expect more of our discoveries and discoveries that we inspire, to reach human trials soon.

Read More


Preventing the Spread of HBV

The hepatitis virus has been affecting various parts of the world, with the worst of it being in Africa and areas of Southeast Asia, as well as China, Japan and India. The United States has felt the effects of liver disease as well, especially with the rise of the opioid crisis. Sharing needles is one of the most common ways that liver disease is spread, and with opioid abuse on the rise in states from California to Pennsylvania, hepatitis B and liver cancer cases are becoming more and more frequent.

The goal of the Baruch S. Blumberg Institute is to prevent hepatitis B from spreading as a result of the opioid crisis and other common causes. We also aim to find ways to help those who are living with liver disease anywhere from California to Japan to India with better methods of treatment. Our non-profit research center extends our solutions to anyone battling Hep B through living science.


The Hepatitis B Foundation

The Baruch S. Blumberg Institute is proudly associated with the Hep B Foundation, a national non-profit organization that has been committed to researching and finding a cure for viral hepatitis for over two decades. Through beginnings as a local organization New Hope, Pa., the foundation has grown into a movement with a global reach. From the United States to China and countries in Southeast Asia, the Hep B Foundation has made its presence known and has put together a variety of international programs focused on raising awareness of liver disease.

You can learn more about the Hep B Foundation here.


Donate to cure Hep B.

The Baruch S. Blumberg Institute is making breakthroughs every day to combat chronic hepatitis, but we can’t do it alone. As a non-profit organization, we rely almost exclusively on funding and donations to power our hepatitis virus research, and those donations come from people like you. When you donate to cure Hep B, you are allowing our researchers to have more access to the resources and technologies that make finding a cure possible.

We humbly encourage you to consider making a donation to the Baruch S. Blumberg Institute. We are a non-profit organization, which means every cent of your donation is going toward medical research for discovering new ways to combat liver disease. With your help, we can help put an end to liver cancer and hepatitis B once and for all.

Donate Today

Areas of Focus

  • focus5

    Drug Discovery & Medicinal Chemistry

    Discovering new medicines for hepatitis B, liver cancer, and other forms of viral hepatitis through integrated chemical and biological approaches. Learn more.

  • focus2

    Biomarker Discovery

    Discovering biomarkers for liver diseases and early, non-invasive diagnosis of liver cancers. Learn more.

  • focus3

    Viral Pathogenesis

    Exploring the mechanism of hepatitis B virus infection and identifying molecular targets for curative therapeutics.

  • focus4

    PCRMRC Research Center

    Translating discoveries in cancer, with a focus on the role of cell and tissue engineering,  and metabolism governing these processes. Learn more.

  • public health

    Public Health

    Decreasing the burden of disease and death from hepatitis B and liver cancer by increasing awareness, testing, and linkage, to cure, prevent, and control these life-threatening liver diseases.Learn more.

  • focus6

    Academic Programs

    Exceptional educational opportunities that combine rigorous academic learning, practical experience, and the use of advanced technologies, for students at every level. Learn more.